Confidential Clinical Trial Database Could Spur Publication – Ex-PhRMA Exec
Executive Summary
Creating a database of clinical trial information that would be accessible to journal editors, but not the public, could help encourage companies to publish certain types of trial information, a former Pharmaceutical Research & Manufacturers of America official said
You may also be interested in...
European Adverse Event Database Will Be Publicly Accessible
The European Medicines Agency is developing an extensive database of all approved products that will include information on ongoing clinical trials and adverse events for each drug
European Adverse Event Database Will Be Publicly Accessible
The European Medicines Agency is developing an extensive database of all approved products that will include information on ongoing clinical trials and adverse events for each drug
Study Result Disclosure Treated As Carefully As FDA Submissions – PhRMA
Drug companies are approaching their clinical trial results disclosures with the same degree of attention as FDA submissions, Pharmaceutical Research & Manufacturers of America VP-Scientific & Regulatory Affairs Caroline Loew said